BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18724016)

  • 1. Effect of intra-coronary nicorandil administration prior to reperfusion in acute ST segment elevation myocardial infarction.
    Lee HC; An SG; Choi JH; Lee TK; Kim J; Kim JH; Chun KJ; Hong TJ; Shin YW; Lee SK
    Circ J; 2008 Sep; 72(9):1425-9. PubMed ID: 18724016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction].
    Wang ZQ; Chen MX; Liu DL; Zheng WX; Cao XZ; Chen H; Huang MF; Luo ZR
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):26-33. PubMed ID: 28100342
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of Early Intracoronary Administration of Nicorandil During Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction.
    Feng C; Liu Y; Wang L; Niu D; Han B
    Heart Lung Circ; 2019 Jun; 28(6):858-865. PubMed ID: 29891250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracoronary Nicorandil and the Prevention of the No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction.
    Qi Q; Niu J; Chen T; Yin H; Wang T; Jiang Z
    Med Sci Monit; 2018 May; 24():2767-2776. PubMed ID: 29726480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of nicorandil to prevent reperfusion injury in patients with acute myocardial infarction: Sigmart Multicenter Angioplasty Revascularization Trial (SMART).
    Ota S; Nishikawa H; Takeuchi M; Nakajima K; Nakamura T; Okamoto S; Setsuda M; Makino K; Yamakado T; Nakano T
    Circ J; 2006 Sep; 70(9):1099-104. PubMed ID: 16936418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of combined intracoronary adenosine and nicorandil on no-reflow phenomenon during percutaneous coronary intervention.
    Lim SY; Bae EH; Jeong MH; Kang DG; Lee YS; Kim KH; Lee SH; Yoon KH; Hong SN; Park HW; Hong YJ; Kim JH; Kim W; Ahn YK; Cho JG; Park JC; Kang JC
    Circ J; 2004 Oct; 68(10):928-32. PubMed ID: 15459466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Suppressive effect of nicorandil in ventricular arrhythmias after reperfusion therapy in patients with acute myocardial infarction].
    Hara H; Horinaka S; Yabe A; Yagi H; Tsuboko Y; Yoshida K; Iemura T; Matsuoka H
    J Cardiol; 2007 Mar; 49(3):135-41. PubMed ID: 17444139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Nicorandil Administration on Infarct Size in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: The CHANGE Trial.
    Qian G; Zhang Y; Dong W; Jiang ZC; Li T; Cheng LQ; Zou YT; Jiang XS; Zhou H; A X; Li P; Chen ML; Su X; Tian JW; Shi B; Li ZZ; Wu YQ; Li YJ; Chen YD
    J Am Heart Assoc; 2022 Sep; 11(18):e026232. PubMed ID: 36073634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of nicorandil administration in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials.
    Geng N; Ren L; Xu L; Zou D; Pang W
    BMC Cardiovasc Disord; 2021 Oct; 21(1):488. PubMed ID: 34629058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction.
    Ishii H; Ichimiya S; Kanashiro M; Amano T; Imai K; Murohara T; Matsubara T
    Circulation; 2005 Aug; 112(9):1284-8. PubMed ID: 16116055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reperfusion arrhythmias: are they only a marker of epicardial reperfusion or continuing myocardial ischemia after acute myocardial infarction?
    Heper G; Korkmaz ME; Kilic A
    Angiology; 2007 Dec-2008 Jan; 58(6):663-70. PubMed ID: 17989422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of nicorandil on ventricular arrhythmia in patients with acute ST-segment elevation myocardial infarction underwent emergent percutaneous coronary intervention treatment].
    Wang YP; Zhang Y; Sun YR; Sun ZG; Zuo ZK; Feng ZR; Chang FY; Xu YC; Chen BZ; Ye YY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Aug; 45(8):701-705. PubMed ID: 28851188
    [No Abstract]   [Full Text] [Related]  

  • 13. Nicorandil in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis.
    Wu M; Huang Z; Xie H; Zhou Z
    PLoS One; 2013; 8(10):e78231. PubMed ID: 24167609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intracoronary anisodamine and diltiazem administration during primary percutaneous coronary intervention in acute myocardial infarction.
    Peng Y; Fu X; Li W; Geng W; Xing K; Ru L; Sun J; Zhao Y
    Coron Artery Dis; 2014 Dec; 25(8):645-52. PubMed ID: 25230304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the Efficacy and Safety of Early Intracoronary Nicorandil Administration in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Gupta H; Parihar S; Tripathi VD
    Cureus; 2022 May; 14(5):e25349. PubMed ID: 35761910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial.
    Gu YL; Kampinga MA; Wieringa WG; Fokkema ML; Nijsten MW; Hillege HL; van den Heuvel AF; Tan ES; Pundziute G; van der Werf R; Hoseyni Guyomi S; van der Horst IC; Zijlstra F; de Smet BJ
    Circulation; 2010 Dec; 122(25):2709-17. PubMed ID: 21098442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of no flow/slow reflow phenomenon in primary PCI by Nicorandil.
    J E; Juneja MS; George T; Sr R; V V; Ak B; Kalyani S; Pandurangi UM; Latchumanadhas K; S MA
    Indian Heart J; 2007; 59(3):246-9. PubMed ID: 19124934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of intracoronary injection of nicorandil and tirofiban on myocardial perfusion and short-term prognosis in elderly patients with acute ST-segment elevation myocardial infarction after emergency PCI.
    Chen GX; Wang HN; Zou JL; Yuan XX
    World J Emerg Med; 2020; 11(3):157-163. PubMed ID: 32351648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracoronary administration of darbepoetin-alpha at onset of reperfusion in acute myocardial infarction: results of the randomized Intra-Co-EpoMI trial.
    Roubille F; Micheau A; Combes S; Thibaut S; Souteyrand G; Cayla G; Bonello L; Lesavre N; Sportouch-Dukhan C; Klein F; Berboucha S; Cade S; Cung TT; Raczka F; Macia JC; Gervasoni R; Cransac F; Leclercq F; Barrère-Lemaire S; Paganelli F; Mottref P; Vernhet Kovacsik H; Ovize M; Piot C
    Arch Cardiovasc Dis; 2013 Mar; 106(3):135-45. PubMed ID: 23582675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction.
    Ito H; Taniyama Y; Iwakura K; Nishikawa N; Masuyama T; Kuzuya T; Hori M; Higashino Y; Fujii K; Minamino T
    J Am Coll Cardiol; 1999 Mar; 33(3):654-60. PubMed ID: 10080465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.